Congenital myasthenic syndrome due to novel CHAT mutations in an ethnic kadazandusun family

Muscle Nerve. 2016 May;53(5):822-6. doi: 10.1002/mus.25037. Epub 2016 Mar 23.

Abstract

Introduction: Choline acetyltransferase (CHAT) gene mutations cause a rare presynaptic congenital myasthenic syndrome due to impaired acetylcholine resynthesis.

Methods: We report 2 Kadazandusun brothers with novel heterozygous CHAT mutations.

Results: The siblings were from a family of 7 children of nonconsanguineous parents, 3 who died from apneic crises. Both presented in infancy with ptosis and exertional limb weakness, but only 1 apnea episode was reported in the older sibling. The elder brother had a positive edrophonium test, and both were negative for acetylcholine receptor antibodies but improved with pyridostigmine treatment. A subsequent repetitive nerve stimulation test showed marked decremental response in the abductor digiti minimi only after prolonged ulnar nerve stimulation. Two novel CHAT gene mutations, p.Val306Leu and p.Ser704del were detected; the parents carried 1 mutation each.

Conclusions: Differences in survival demonstrate phenotypic variability within the same family and a relatively good long-term outcome of the surviving siblings.

Keywords: CHAT; Kadazandusun; apneic episodes; choline acetyltransferase; congenital myasthenic syndrome; novel mutations.

MeSH terms

  • Asian People
  • Choline O-Acetyltransferase / genetics*
  • Cholinesterase Inhibitors / therapeutic use
  • Heterozygote*
  • Humans
  • Malaysia
  • Male
  • Mutation
  • Myasthenic Syndromes, Congenital / drug therapy
  • Myasthenic Syndromes, Congenital / genetics*
  • Pedigree*
  • Pyridostigmine Bromide / therapeutic use
  • Siblings
  • Young Adult

Substances

  • Cholinesterase Inhibitors
  • Choline O-Acetyltransferase
  • Pyridostigmine Bromide